My bookmarksSign up free

Commission Regulation (EU) No 722/2012 ANNEX II

Commission Regulation (EU) No 722/2012 ANNEX II

ANNEX IISupplementary provisions

ANNEX II Summary Evaluation Report in accordance with Article 5(4) of Regulation (EU) No 722/2012 Details relating to the submitting notified body 1. Name of notified body 2. Notified body number 3. Country 4. Sent by 5. Contact person 6. Telephone 7. Fax 8. E-mail 9. Client reference (name of manufacturer and, if applicable, of authorised representative) 10. Confirmation that, in accordance with Article 11 of Directive 90/385/EEC and Article 16 of Directive 93/42/EEC, respectively, and Article 4 of Regulation (EU) No 722/2012, the submitting notified body has been designated by its competent authority for the conformity assessment of  active implantable medical devices manufactured utilising tissues of animal origin subject to Regulation (EU) No 722/2012,  medical devices manufactured utilising tissues of animal origin subject to Regulation (EU) No 722/2012 Data relating to the (active implantable) medical device 11. (a)  Active implantable medical device  Other medical device 11. (b) Product description and composition 12. Information on intended use 13.   Starting material 13. (a) EDQM certificate available  YES  NO (If the EDQM certificate is available, it must be submitted with this summary evaluation report.) 13. (b) Information regarding — the nature of the starting tissue(s): — animal species(s): — geographical source(s): 14. A description of the key elements adopted to minimise the risk of infection: 15. An estimate of the TSE risk arising from the use of the product, taking into account the likelihood of contamination of the product, the nature and duration of patient exposure: 16. A justification for the use of animal tissues or derivatives in the medical device, including a rationale for the acceptability of the overall TSE risk estimate, the evaluation of alternative materials and the expected clinical benefit: 17. The approach to the auditing of source establishments and suppliers for the animal material used by the device manufacturer: Notified Body Statement 18. Conclusion of this assessment: Based on the evaluation of data and the assessment process it is our preliminary decision that the application meets the requirements of conformity with  Council Directive 90/385/EEC  Council Directive 93/42/EEC and Regulation (EU) No 722/2012. Date of submission 19. This report was sent on … to the Coordinating Competent Authority of … to inform the Competent Authorities of the other Member States and the Commission and to seek their comments, if any.

Read the full instrument →

Other provisions in Commission Regulation (EU) No 722/2012

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX II of Commission Regulation (EU) No 722/2012 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next